Quick Dispatch:
Your national shortage of semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your national shortage of semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s ships.
Need Help?
Questions about national shortage of semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for national shortage of semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s in your area.
The FDA has removed semaglutide injection products (GLP-1) from the shortage list, ending the temporary rule that allowed pharmacies to compound these medications, often used for weight loss. Compounded drugs are custom-made
29.64
FDA Ends Semaglutide Shortage Listing, Contributing to Ongoing Legal Challenges
24.80
FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic Over
29.97
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
23.44
Compounded medications are permitted by the FDA in times of shortage. That was present from 2021-2024 (tirzepatide) and 2025 (semaglutide). That has ended. The last two year grace period of continued
24.89
Hims: Why The Semaglutide Shortage May End Imminently
21.25
Ozempic and Wegovy are no longer in shortage, FDA says
25.97
